112 related articles for article (PubMed ID: 3816915)
1. Natural killer activity of blood lymphocytes in patients with primary intracranial tumors. Correlation to histological tumor type and anatomical site.
Ullén H; Blom U; Blomgren H
Eur J Cancer Clin Oncol; 1986 Oct; 22(10):1239-45. PubMed ID: 3816915
[TBL] [Abstract][Full Text] [Related]
2. Capacity of sera from patients with primary intracranial tumors to support mitogen stimulation of blood lymphocytes. Correlation to histological tumor type.
Blomgren H; Blom U; Ullén H
Anticancer Res; 1985; 5(4):349-54. PubMed ID: 4037733
[TBL] [Abstract][Full Text] [Related]
3. Mitogen stimulation of blood lymphocytes from patients with primary intracranial tumors. Correlation to histological tumor type.
Blom U; Blomgren H; Ullén H; Collins P; Von Holst H
Anticancer Res; 1985; 5(4):343-8. PubMed ID: 4037732
[TBL] [Abstract][Full Text] [Related]
4. Blood lymphocyte subsets in patients with primary intracranial tumours. Correlation to histological tumour type and anatomical site.
Ullén H; Blom U; Blomgren H; von Holst H
Acta Neurochir (Wien); 1986; 81(3-4):100-5. PubMed ID: 3489354
[TBL] [Abstract][Full Text] [Related]
5. Lymphocytic infiltration in gliomas: evidence of possible host resistance.
Ridley A; Cavanagh JB
Brain; 1971; 94(1):117-24. PubMed ID: 5552158
[No Abstract] [Full Text] [Related]
6. [Changes of natural killer activity following local 60Co irradiation in intracranial tumor-bearing mice (author's transl)].
Otsuka S; Suda K; Yamashita J; Takeuchi J; Handa H
No To Shinkei; 1982 Apr; 34(4):393-8. PubMed ID: 7093076
[TBL] [Abstract][Full Text] [Related]
7. Antigenic heterogeneity of human brain tumors defined by monoclonal antibodies.
Stavrou D; Bise K; Groeneveld J; Stocker U; Kretzschmar HA; Keiditsch E; Mehraein P
Anticancer Res; 1989; 9(6):1489-96. PubMed ID: 2697177
[TBL] [Abstract][Full Text] [Related]
8. [The effect of local injection of interferon against human malignant glioma transplanted into nude mice and the mechanism of its effect].
Hori T; Inoue Y; Hokama Y; Yamamoto F; Iwanaga M; Watanabe T
No To Shinkei; 1989 Sep; 41(9):911-7. PubMed ID: 2590560
[TBL] [Abstract][Full Text] [Related]
9. Microglia in brain tumors.
Graeber MB; Scheithauer BW; Kreutzberg GW
Glia; 2002 Nov; 40(2):252-259. PubMed ID: 12379912
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory infiltrates and natural killer cell presence in human brain tumors.
Stevens A; Klöter I; Roggendorf W
Cancer; 1988 Feb; 61(4):738-43. PubMed ID: 3338036
[TBL] [Abstract][Full Text] [Related]
11. T lymphocyte subsets and immunoglobulins in intracranial tumor patients before and after treatment, and based on histological type of tumors.
Kempuraj D; Devi RS; Madhappan B; Conti P; Nazer MY; Christodoulou S; Reginald J; Suthinthirarajan N; Namasivayam A
Int J Immunopathol Pharmacol; 2004; 17(1):57-64. PubMed ID: 15000867
[TBL] [Abstract][Full Text] [Related]
12. [Natural killer activity of peripheral blood lymphocytes in patients with brain tumors].
Otsuka S; Suda K; Yamashita J; Takeuchi J; Handa H
No Shinkei Geka; 1982 Dec; 10(12):1291-7. PubMed ID: 7170068
[No Abstract] [Full Text] [Related]
13. IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression.
Zhang X; Rao A; Sette P; Deibert C; Pomerantz A; Kim WJ; Kohanbash G; Chang Y; Park Y; Engh J; Choi J; Chan T; Okada H; Lotze M; Grandi P; Amankulor N
Neuro Oncol; 2016 Oct; 18(10):1402-12. PubMed ID: 27116977
[TBL] [Abstract][Full Text] [Related]
14. [Activity of the natural killer cells in the peripheral blood of patients with brain tumors].
Lisianyĭ NI; Markova OV; Zhmareva EN
Eksp Onkol; 1988; 10(3):57-9. PubMed ID: 3409835
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of glioma and fetal brain cell lines to natural killer cytolysis in a monolayer assay.
Kazimer RM; Whisler RL; Stephens RE; Pearl DK; Yates AJ
J Neurooncol; 1989 Jul; 7(2):145-50. PubMed ID: 2778490
[TBL] [Abstract][Full Text] [Related]
16. T cell adoptive immunotherapy of newly diagnosed gliomas.
Plautz GE; Miller DW; Barnett GH; Stevens GH; Maffett S; Kim J; Cohen PA; Shu S
Clin Cancer Res; 2000 Jun; 6(6):2209-18. PubMed ID: 10873070
[TBL] [Abstract][Full Text] [Related]
17. Some remarks on adherence reactivity of autologous PHA--transformed lymphocytes on human glial tumor cells in vitro.
Kałuza J; Krzyszkowski T
Folia Neuropathol; 1994; 32(1):21-30. PubMed ID: 7922099
[TBL] [Abstract][Full Text] [Related]
18. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the mononuclear cell infiltrate and HLA-Dr expression in 19 oligodendrogliomas.
Rossi ML; Esiri MM; Jones NR; Coakham HB; Moss TH; Cruz-Sanchez FF; Carey MP
Surg Neurol; 1991 Aug; 36(2):119-25. PubMed ID: 1891756
[TBL] [Abstract][Full Text] [Related]
20. Autologous natural killer cell therapy for human recurrent malignant glioma.
Ishikawa E; Tsuboi K; Saijo K; Harada H; Takano S; Nose T; Ohno T
Anticancer Res; 2004; 24(3b):1861-71. PubMed ID: 15274367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
